Kassoum Nacro

Singapore, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

ETC-501 Is a Brain-Penetrant MNK Inhibitor That Potentiates TMZ-Induced Senescence and Sensitizes Glioblastoma Cells to Senolytic Therapy.

ETC-501 Is a Brain-Penetrant MNK Inhibitor That Potentiates TMZ-Induced Senescence and Sensitizes Glioblastoma Cells to Senolytic Therapy.

Journal: Cancer research

Published: November 24, 2024

Identification of small-molecule binding sites of a ubiquitin-conjugating enzyme-UBE2T through fragment-based screening.

Identification of small-molecule binding sites of a ubiquitin-conjugating enzyme-UBE2T through fragment-based screening.

Journal: Protein science : a publication of the Protein Society

Published: November 13, 2023

Update on the Development of MNK Inhibitors as Therapeutic Agents.

Update on the Development of MNK Inhibitors as Therapeutic Agents.

Journal: Journal of medicinal chemistry

Published: September 17, 2021

Topography of transcriptionally active chromatin in glioblastoma.

Topography of transcriptionally active chromatin in glioblastoma.

Journal: Science advances

Published: July 07, 2020

MNK1 and MNK2 enforce expression of E2F1, FOXM1, and WEE1 to drive soft tissue sarcoma.

MNK1 and MNK2 enforce expression of E2F1, FOXM1, and WEE1 to drive soft tissue sarcoma.

Journal: Oncogene

Published: May 30, 2020

Stepwise Evolution of Fragment Hits against MAPK Interacting Kinases 1 and 2.

Stepwise Evolution of Fragment Hits against MAPK Interacting Kinases 1 and 2.

Journal: Journal of medicinal chemistry

Published: January 08, 2020

Rescue of oxytocin response and social behaviour in a mouse model of autism.

Rescue of oxytocin response and social behaviour in a mouse model of autism.

Journal: Nature

Published: May 20, 2019

Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia.

Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia.

Journal: Journal of medicinal chemistry

Published: April 24, 2018

Correction to Probing the Binding Mechanism of Mnk Inhibitors by Docking and Molecular Dynamics Simulations.

Correction to Probing the Binding Mechanism of Mnk Inhibitors by Docking and Molecular Dynamics Simulations.

Journal: Biochemistry

Published: October 28, 2017

Structural Insights into the Inhibition of Zika Virus NS2B-NS3 Protease by a Small-Molecule Inhibitor.

Structural Insights into the Inhibition of Zika Virus NS2B-NS3 Protease by a Small-Molecule Inhibitor.

Journal: Structure (London, England : 1993)

Published: October 24, 2017

Structure-Activity Relationship Studies of Mitogen Activated Protein Kinase Interacting Kinase (MNK) 1 and 2 and BCR-ABL1 Inhibitors Targeting Chronic Myeloid Leukemic Cells.

Structure-Activity Relationship Studies of Mitogen Activated Protein Kinase Interacting Kinase (MNK) 1 and 2 and BCR-ABL1 Inhibitors Targeting Chronic Myeloid Leukemic Cells.

Journal: Journal of medicinal chemistry

Published: March 25, 2016

Identification of covalent active site inhibitors of dengue virus protease.

Identification of covalent active site inhibitors of dengue virus protease.

Journal: Drug design, development and therapy

Published: December 18, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026